Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma
Status:
Unknown status
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
Multicenter, double-blinding, randomized controlled, phase II clinical trial on combined
chemotherapy of Endostar (Recombinant Human Endostatin) for untreated patients with advanced
melanoma, To compare the efficacy and safety of Endostar combined with Dacarbazine and
monotherapy of Dacarbazine for advanced melanoma